Article
Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.
Blood - 27 Jun 2019
Luchtel Rebecca A, Zimmermann Michael T, Hu Guangzhen, Dasari Surendra, Jiang Manli, Oishi Naoki, Jacobs Hailey K, Zeng Yu, Hundal Tanya, Rech Karen L, Ketterling Rhett P, Lee Jeong-Heon, Eckloff Bruce W, Yan Huihuang, Gaonkar Krutika S, Tian Shulan, Ye Zhenqing, Kadin Marshall E, Sidhu Jagmohan, Jiang Liuyan, Voss Jesse, Link Brian K, Syrbu Sergei I, Facchetti Fabio, Bennani N Nora, Slager Susan L, Ordog Tamas, Kocher Jean-Pierre, Cerhan James R, Ansell Stephen M, Feldman Andrew L
Abstract excerpt
Anaplastic large cell lymphomas (ALCLs) represent a relatively common group of T-cell non-Hodgkin lymphomas (T-NHLs) that are unified by similar pathologic features but demonstrate marked genetic heterogeneity. ALCLs are broadly classified as being anaplastic lymphoma kinase (ALK)+ or ALK-, based on the presence or absence of ALK rearrangements. Exome sequencing of 62 T-NHLs identified a previously unreported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
